Nevro Corp NVRO:NYSE

Last Price$43.44Cboe Closing Price as of 3:59PM ET 12/05/22
Cboe Real-Time Quotes
Today's Change-1.75(3.87%)
Bid (Size)$39.53 (100)
Ask (Size)$47.42 (100)
Day Low / High$43.41 - 45.03
Volume274.3 K
  • Latest Stories
  • Commentary and Analysis
--Piper Sandler Adjusts Price Target on Nevro to $42 From $45, Maintains Neutral Rating
12:36PM ET 11/03/2022 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

-- Earnings Flash (NVRO) NEVRO Posts Q3 Revenue $86.1M, vs. Street Est of $99.2M
4:15PM ET 11/02/2022 MT Newswires

...

Nevro Says FDA Approved Its Senza HFX iQ Spinal Cord Stimulation System
4:23AM ET 10/13/2022 MT Newswires

Nevro (NVRO) said Wednesday the US Food and Drug Administration has approved its Senza HFX iQ spinal cord stimulation system. The company said the...

Nevro Shares Down After Jefferies Initiates Coverage at Underperform
11:42AM ET 10/12/2022 MT Newswires

Nevro (NVRO) shares were down 4.9% around midday Wednesday after Jefferies initiated coverage with an underperform rating and a $31 price target. Trading...

--Jefferies Starts Nevro at Underperform With $31 Price Target
7:40AM ET 10/12/2022 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

--Morgan Stanley Adjusts Nevro's Price Target to $49 from $54, Reiterates Equalweight Rating
12:33PM ET 10/11/2022 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

Nevro Says UnitedHealthcare's Updated Coverage Policy Won't Have 'Material Impact' on Revenue; Shares Rise Pre-Bell
9:29AM ET 10/10/2022 MT Newswires

Nevro (NVRO) said Monday UnitedHealthcare's (UNH) updated medical coverage policy for spinal cord stimulation devices isn't expected to have a "material...

Nevro Gets FDA Approval for Costa Rica Manufacturing Facility
4:14PM ET 10/04/2022 MT Newswires

Nevro (NVRO) said Tuesday that the US Food and Drug Administration approved its manufacturing operations in Costa Rica for the production of its spinal...

--Wells Fargo Securities Adjusts Nevro's Price Target to $86 From $90, Reiterates Overweight Rating
12:31PM ET 8/04/2022 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

--Piper Sandler Adjusts Nevro's Price Target to $45 From $64, Maintains Neutral Rating
6:50AM ET 8/04/2022 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...